カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の小児科用呼吸器治療薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Pediatrics Respiratory Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19519）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19519
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：94
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の小児科用呼吸器治療薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

小児科用呼吸器治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の小児科用呼吸器治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

小児科用呼吸器治療薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・粉末吸入、経口

用途別セグメントは次のように区分されます。
・病院、診療所、その他

世界の小児科用呼吸器治療薬市場の主要な市場プレーヤーは以下のとおりです。
・Mylan、Armstrong Pharmaceuticals、GlaxoSmithKline、Valeant Pharmaceuticals、Merck、Endo International、Bauch & Lomb、Boehringer Ingelheim

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、小児科用呼吸器治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な小児科用呼吸器治療薬メーカーの企業概要、2019年～2022年までの小児科用呼吸器治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な小児科用呼吸器治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別小児科用呼吸器治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの小児科用呼吸器治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での小児科用呼吸器治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および小児科用呼吸器治療薬の産業チェーンを掲載しています。
・第13、14、15章では、小児科用呼吸器治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 小児科用呼吸器治療薬の概要
- 種類別分析（2017年vs2021年vs2028年）：粉末吸入、経口
- 用途別分析（2017年vs2021年vs2028年）：病院、診療所、その他
- 世界の小児科用呼吸器治療薬市場規模・予測
- 世界の小児科用呼吸器治療薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Mylan、Armstrong Pharmaceuticals、GlaxoSmithKline、Valeant Pharmaceuticals、Merck、Endo International、Bauch & Lomb、Boehringer Ingelheim
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：粉末吸入、経口
・用途別分析2017年-2028年：病院、診療所、その他
・小児科用呼吸器治療薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・小児科用呼吸器治療薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・小児科用呼吸器治療薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・小児科用呼吸器治療薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・小児科用呼吸器治療薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Pediatrics Respiratory Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pediatrics Respiratory Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Pediatrics Respiratory Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Powder Inhalation segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Pediatrics Respiratory Drugs include Mylan, Armstrong Pharmaceuticals, GlaxoSmithKline, Valeant Pharmaceuticals, and Merck, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pediatrics Respiratory Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Powder Inhalation
Oral
Market segment by Application can be divided into
Hospitals
Clinics
Others
The key market players for global Pediatrics Respiratory Drugs market are listed below:
Mylan
Armstrong Pharmaceuticals
GlaxoSmithKline
Valeant Pharmaceuticals
Merck
Endo International
Bauch & Lomb
Boehringer Ingelheim
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pediatrics Respiratory Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pediatrics Respiratory Drugs, with price, sales, revenue and global market share of Pediatrics Respiratory Drugs from 2019 to 2022.
Chapter 3, the Pediatrics Respiratory Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pediatrics Respiratory Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Pediatrics Respiratory Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pediatrics Respiratory Drugs.
Chapter 13, 14, and 15, to describe Pediatrics Respiratory Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Pediatrics Respiratory Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pediatrics Respiratory Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Powder Inhalation
1.2.3 Oral
1.3 Market Analysis by Application
1.3.1 Overview: Global Pediatrics Respiratory Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Pediatrics Respiratory Drugs Market Size & Forecast
1.4.1 Global Pediatrics Respiratory Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Pediatrics Respiratory Drugs Sales in Volume (2017-2028)
1.4.3 Global Pediatrics Respiratory Drugs Price (2017-2028)
1.5 Global Pediatrics Respiratory Drugs Production Capacity Analysis
1.5.1 Global Pediatrics Respiratory Drugs Total Production Capacity (2017-2028)
1.5.2 Global Pediatrics Respiratory Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pediatrics Respiratory Drugs Market Drivers
1.6.2 Pediatrics Respiratory Drugs Market Restraints
1.6.3 Pediatrics Respiratory Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Mylan
2.1.1 Mylan Details
2.1.2 Mylan Major Business
2.1.3 Mylan Pediatrics Respiratory Drugs Product and Services
2.1.4 Mylan Pediatrics Respiratory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Armstrong Pharmaceuticals
2.2.1 Armstrong Pharmaceuticals Details
2.2.2 Armstrong Pharmaceuticals Major Business
2.2.3 Armstrong Pharmaceuticals Pediatrics Respiratory Drugs Product and Services
2.2.4 Armstrong Pharmaceuticals Pediatrics Respiratory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Pediatrics Respiratory Drugs Product and Services
2.3.4 GlaxoSmithKline Pediatrics Respiratory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Valeant Pharmaceuticals
2.4.1 Valeant Pharmaceuticals Details
2.4.2 Valeant Pharmaceuticals Major Business
2.4.3 Valeant Pharmaceuticals Pediatrics Respiratory Drugs Product and Services
2.4.4 Valeant Pharmaceuticals Pediatrics Respiratory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Pediatrics Respiratory Drugs Product and Services
2.5.4 Merck Pediatrics Respiratory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Endo International
2.6.1 Endo International Details
2.6.2 Endo International Major Business
2.6.3 Endo International Pediatrics Respiratory Drugs Product and Services
2.6.4 Endo International Pediatrics Respiratory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Bauch & Lomb
2.7.1 Bauch & Lomb Details
2.7.2 Bauch & Lomb Major Business
2.7.3 Bauch & Lomb Pediatrics Respiratory Drugs Product and Services
2.7.4 Bauch & Lomb Pediatrics Respiratory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Boehringer Ingelheim
2.8.1 Boehringer Ingelheim Details
2.8.2 Boehringer Ingelheim Major Business
2.8.3 Boehringer Ingelheim Pediatrics Respiratory Drugs Product and Services
2.8.4 Boehringer Ingelheim Pediatrics Respiratory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Pediatrics Respiratory Drugs Breakdown Data by Manufacturer
3.1 Global Pediatrics Respiratory Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Pediatrics Respiratory Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Pediatrics Respiratory Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Pediatrics Respiratory Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Pediatrics Respiratory Drugs Manufacturer Market Share in 2021
3.5 Global Pediatrics Respiratory Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Pediatrics Respiratory Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pediatrics Respiratory Drugs Market Size by Region
4.1.1 Global Pediatrics Respiratory Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Pediatrics Respiratory Drugs Revenue by Region (2017-2028)
4.2 North America Pediatrics Respiratory Drugs Revenue (2017-2028)
4.3 Europe Pediatrics Respiratory Drugs Revenue (2017-2028)
4.4 Asia-Pacific Pediatrics Respiratory Drugs Revenue (2017-2028)
4.5 South America Pediatrics Respiratory Drugs Revenue (2017-2028)
4.6 Middle East and Africa Pediatrics Respiratory Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Pediatrics Respiratory Drugs Sales in Volume by Type (2017-2028)
5.2 Global Pediatrics Respiratory Drugs Revenue by Type (2017-2028)
5.3 Global Pediatrics Respiratory Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Pediatrics Respiratory Drugs Sales in Volume by Application (2017-2028)
6.2 Global Pediatrics Respiratory Drugs Revenue by Application (2017-2028)
6.3 Global Pediatrics Respiratory Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Pediatrics Respiratory Drugs Sales by Type (2017-2028)
7.2 North America Pediatrics Respiratory Drugs Sales by Application (2017-2028)
7.3 North America Pediatrics Respiratory Drugs Market Size by Country
7.3.1 North America Pediatrics Respiratory Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Pediatrics Respiratory Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Pediatrics Respiratory Drugs Sales by Type (2017-2028)
8.2 Europe Pediatrics Respiratory Drugs Sales by Application (2017-2028)
8.3 Europe Pediatrics Respiratory Drugs Market Size by Country
8.3.1 Europe Pediatrics Respiratory Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Pediatrics Respiratory Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Pediatrics Respiratory Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Pediatrics Respiratory Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Pediatrics Respiratory Drugs Market Size by Region
9.3.1 Asia-Pacific Pediatrics Respiratory Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Pediatrics Respiratory Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Pediatrics Respiratory Drugs Sales by Type (2017-2028)
10.2 South America Pediatrics Respiratory Drugs Sales by Application (2017-2028)
10.3 South America Pediatrics Respiratory Drugs Market Size by Country
10.3.1 South America Pediatrics Respiratory Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Pediatrics Respiratory Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pediatrics Respiratory Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Pediatrics Respiratory Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Pediatrics Respiratory Drugs Market Size by Country
11.3.1 Middle East & Africa Pediatrics Respiratory Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Pediatrics Respiratory Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Pediatrics Respiratory Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Pediatrics Respiratory Drugs
12.3 Pediatrics Respiratory Drugs Production Process
12.4 Pediatrics Respiratory Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Pediatrics Respiratory Drugs Typical Distributors
13.3 Pediatrics Respiratory Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Pediatrics Respiratory Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Pediatrics Respiratory Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Mylan Basic Information, Manufacturing Base and Competitors
Table 4. Mylan Major Business
Table 5. Mylan Pediatrics Respiratory Drugs Product and Services
Table 6. Mylan Pediatrics Respiratory Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Armstrong Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Armstrong Pharmaceuticals Major Business
Table 9. Armstrong Pharmaceuticals Pediatrics Respiratory Drugs Product and Services
Table 10. Armstrong Pharmaceuticals Pediatrics Respiratory Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 12. GlaxoSmithKline Major Business
Table 13. GlaxoSmithKline Pediatrics Respiratory Drugs Product and Services
Table 14. GlaxoSmithKline Pediatrics Respiratory Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Valeant Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Valeant Pharmaceuticals Major Business
Table 17. Valeant Pharmaceuticals Pediatrics Respiratory Drugs Product and Services
Table 18. Valeant Pharmaceuticals Pediatrics Respiratory Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Merck Basic Information, Manufacturing Base and Competitors
Table 20. Merck Major Business
Table 21. Merck Pediatrics Respiratory Drugs Product and Services
Table 22. Merck Pediatrics Respiratory Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Endo International Basic Information, Manufacturing Base and Competitors
Table 24. Endo International Major Business
Table 25. Endo International Pediatrics Respiratory Drugs Product and Services
Table 26. Endo International Pediatrics Respiratory Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Bauch & Lomb Basic Information, Manufacturing Base and Competitors
Table 28. Bauch & Lomb Major Business
Table 29. Bauch & Lomb Pediatrics Respiratory Drugs Product and Services
Table 30. Bauch & Lomb Pediatrics Respiratory Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 32. Boehringer Ingelheim Major Business
Table 33. Boehringer Ingelheim Pediatrics Respiratory Drugs Product and Services
Table 34. Boehringer Ingelheim Pediatrics Respiratory Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Pediatrics Respiratory Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 36. Global Pediatrics Respiratory Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Pediatrics Respiratory Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Pediatrics Respiratory Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Pediatrics Respiratory Drugs Production Site of Key Manufacturer
Table 40. Pediatrics Respiratory Drugs New Entrant and Capacity Expansion Plans
Table 41. Pediatrics Respiratory Drugs Mergers & Acquisitions in the Past Five Years
Table 42. Global Pediatrics Respiratory Drugs Sales by Region (2017-2022) & (K Units)
Table 43. Global Pediatrics Respiratory Drugs Sales by Region (2023-2028) & (K Units)
Table 44. Global Pediatrics Respiratory Drugs Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Pediatrics Respiratory Drugs Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Pediatrics Respiratory Drugs Sales by Type (2017-2022) & (K Units)
Table 47. Global Pediatrics Respiratory Drugs Sales by Type (2023-2028) & (K Units)
Table 48. Global Pediatrics Respiratory Drugs Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Pediatrics Respiratory Drugs Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Pediatrics Respiratory Drugs Price by Type (2017-2022) & (US$/Unit)
Table 51. Global Pediatrics Respiratory Drugs Price by Type (2023-2028) & (US$/Unit)
Table 52. Global Pediatrics Respiratory Drugs Sales by Application (2017-2022) & (K Units)
Table 53. Global Pediatrics Respiratory Drugs Sales by Application (2023-2028) & (K Units)
Table 54. Global Pediatrics Respiratory Drugs Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Pediatrics Respiratory Drugs Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Pediatrics Respiratory Drugs Price by Application (2017-2022) & (US$/Unit)
Table 57. Global Pediatrics Respiratory Drugs Price by Application (2023-2028) & (US$/Unit)
Table 58. North America Pediatrics Respiratory Drugs Sales by Country (2017-2022) & (K Units)
Table 59. North America Pediatrics Respiratory Drugs Sales by Country (2023-2028) & (K Units)
Table 60. North America Pediatrics Respiratory Drugs Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Pediatrics Respiratory Drugs Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Pediatrics Respiratory Drugs Sales by Type (2017-2022) & (K Units)
Table 63. North America Pediatrics Respiratory Drugs Sales by Type (2023-2028) & (K Units)
Table 64. North America Pediatrics Respiratory Drugs Sales by Application (2017-2022) & (K Units)
Table 65. North America Pediatrics Respiratory Drugs Sales by Application (2023-2028) & (K Units)
Table 66. Europe Pediatrics Respiratory Drugs Sales by Country (2017-2022) & (K Units)
Table 67. Europe Pediatrics Respiratory Drugs Sales by Country (2023-2028) & (K Units)
Table 68. Europe Pediatrics Respiratory Drugs Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Pediatrics Respiratory Drugs Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Pediatrics Respiratory Drugs Sales by Type (2017-2022) & (K Units)
Table 71. Europe Pediatrics Respiratory Drugs Sales by Type (2023-2028) & (K Units)
Table 72. Europe Pediatrics Respiratory Drugs Sales by Application (2017-2022) & (K Units)
Table 73. Europe Pediatrics Respiratory Drugs Sales by Application (2023-2028) & (K Units)
Table 74. Asia-Pacific Pediatrics Respiratory Drugs Sales by Region (2017-2022) & (K Units)
Table 75. Asia-Pacific Pediatrics Respiratory Drugs Sales by Region (2023-2028) & (K Units)
Table 76. Asia-Pacific Pediatrics Respiratory Drugs Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Pediatrics Respiratory Drugs Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Pediatrics Respiratory Drugs Sales by Type (2017-2022) & (K Units)
Table 79. Asia-Pacific Pediatrics Respiratory Drugs Sales by Type (2023-2028) & (K Units)
Table 80. Asia-Pacific Pediatrics Respiratory Drugs Sales by Application (2017-2022) & (K Units)
Table 81. Asia-Pacific Pediatrics Respiratory Drugs Sales by Application (2023-2028) & (K Units)
Table 82. South America Pediatrics Respiratory Drugs Sales by Country (2017-2022) & (K Units)
Table 83. South America Pediatrics Respiratory Drugs Sales by Country (2023-2028) & (K Units)
Table 84. South America Pediatrics Respiratory Drugs Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Pediatrics Respiratory Drugs Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Pediatrics Respiratory Drugs Sales by Type (2017-2022) & (K Units)
Table 87. South America Pediatrics Respiratory Drugs Sales by Type (2023-2028) & (K Units)
Table 88. South America Pediatrics Respiratory Drugs Sales by Application (2017-2022) & (K Units)
Table 89. South America Pediatrics Respiratory Drugs Sales by Application (2023-2028) & (K Units)
Table 90. Middle East & Africa Pediatrics Respiratory Drugs Sales by Region (2017-2022) & (K Units)
Table 91. Middle East & Africa Pediatrics Respiratory Drugs Sales by Region (2023-2028) & (K Units)
Table 92. Middle East & Africa Pediatrics Respiratory Drugs Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Pediatrics Respiratory Drugs Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Pediatrics Respiratory Drugs Sales by Type (2017-2022) & (K Units)
Table 95. Middle East & Africa Pediatrics Respiratory Drugs Sales by Type (2023-2028) & (K Units)
Table 96. Middle East & Africa Pediatrics Respiratory Drugs Sales by Application (2017-2022) & (K Units)
Table 97. Middle East & Africa Pediatrics Respiratory Drugs Sales by Application (2023-2028) & (K Units)
Table 98. Pediatrics Respiratory Drugs Raw Material
Table 99. Key Manufacturers of Pediatrics Respiratory Drugs Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Pediatrics Respiratory Drugs Typical Distributors
Table 103. Pediatrics Respiratory Drugs Typical Customers
List of Figures
Figure 1. Pediatrics Respiratory Drugs Picture
Figure 2. Global Pediatrics Respiratory Drugs Revenue Market Share by Type in 2021
Figure 3. Powder Inhalation
Figure 4. Oral
Figure 5. Global Pediatrics Respiratory Drugs Revenue Market Share by Application in 2021
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Others
Figure 9. Global Pediatrics Respiratory Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Pediatrics Respiratory Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Pediatrics Respiratory Drugs Sales (2017-2028) & (K Units)
Figure 12. Global Pediatrics Respiratory Drugs Price (2017-2028) & (US$/Unit)
Figure 13. Global Pediatrics Respiratory Drugs Production Capacity (2017-2028) & (K Units)
Figure 14. Global Pediatrics Respiratory Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Pediatrics Respiratory Drugs Market Drivers
Figure 16. Pediatrics Respiratory Drugs Market Restraints
Figure 17. Pediatrics Respiratory Drugs Market Trends
Figure 18. Global Pediatrics Respiratory Drugs Sales Market Share by Manufacturer in 2021
Figure 19. Global Pediatrics Respiratory Drugs Revenue Market Share by Manufacturer in 2021
Figure 20. Pediatrics Respiratory Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Pediatrics Respiratory Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Pediatrics Respiratory Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Pediatrics Respiratory Drugs Sales Market Share by Region (2017-2028)
Figure 24. Global Pediatrics Respiratory Drugs Revenue Market Share by Region (2017-2028)
Figure 25. North America Pediatrics Respiratory Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Europe Pediatrics Respiratory Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Pediatrics Respiratory Drugs Revenue (2017-2028) & (USD Million)
Figure 28. South America Pediatrics Respiratory Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Pediatrics Respiratory Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Global Pediatrics Respiratory Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global Pediatrics Respiratory Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global Pediatrics Respiratory Drugs Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Pediatrics Respiratory Drugs Sales Market Share by Application (2017-2028)
Figure 34. Global Pediatrics Respiratory Drugs Revenue Market Share by Application (2017-2028)
Figure 35. Global Pediatrics Respiratory Drugs Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Pediatrics Respiratory Drugs Sales Market Share by Type (2017-2028)
Figure 37. North America Pediatrics Respiratory Drugs Sales Market Share by Application (2017-2028)
Figure 38. North America Pediatrics Respiratory Drugs Sales Market Share by Country (2017-2028)
Figure 39. North America Pediatrics Respiratory Drugs Revenue Market Share by Country (2017-2028)
Figure 40. United States Pediatrics Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Pediatrics Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Pediatrics Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Pediatrics Respiratory Drugs Sales Market Share by Type (2017-2028)
Figure 44. Europe Pediatrics Respiratory Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Pediatrics Respiratory Drugs Sales Market Share by Country (2017-2028)
Figure 46. Europe Pediatrics Respiratory Drugs Revenue Market Share by Country (2017-2028)
Figure 47. Germany Pediatrics Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Pediatrics Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Pediatrics Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Pediatrics Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Pediatrics Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Pediatrics Respiratory Drugs Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Pediatrics Respiratory Drugs Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Pediatrics Respiratory Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Pediatrics Respiratory Drugs Revenue Market Share by Region (2017-2028)
Figure 56. China Pediatrics Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Pediatrics Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Pediatrics Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Pediatrics Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Pediatrics Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Pediatrics Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Pediatrics Respiratory Drugs Sales Market Share by Type (2017-2028)
Figure 63. South America Pediatrics Respiratory Drugs Sales Market Share by Application (2017-2028)
Figure 64. South America Pediatrics Respiratory Drugs Sales Market Share by Country (2017-2028)
Figure 65. South America Pediatrics Respiratory Drugs Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Pediatrics Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Pediatrics Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Pediatrics Respiratory Drugs Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Pediatrics Respiratory Drugs Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Pediatrics Respiratory Drugs Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Pediatrics Respiratory Drugs Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Pediatrics Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Pediatrics Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Pediatrics Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Pediatrics Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Pediatrics Respiratory Drugs in 2021
Figure 77. Manufacturing Process Analysis of Pediatrics Respiratory Drugs
Figure 78. Pediatrics Respiratory Drugs Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の呼吸器治療用処方薬市場2022年：市場規模予測（～2028年）
  • 世界の呼吸器用ゼブラガイドワイヤー市場2022年：市場規模予測（～2028年）
  • 世界の呼吸器パネルアッセイ市場2022年：市場規模予測（～2028年）
  • 世界の呼吸機能モニター市場2022年：市場規模予測（～2028年）
  • 世界の治療用呼吸装置市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19519 )"世界の小児科用呼吸器治療薬市場2022年：市場規模予測（～2028年）" (英文：Global Pediatrics Respiratory Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。